| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm | 63 | 2022 | 644 | 5.420 |
Why?
|
| Aortic Aneurysm, Thoracic | 52 | 2022 | 691 | 5.370 |
Why?
|
| Marfan Syndrome | 17 | 2023 | 240 | 2.620 |
Why?
|
| Aortic Diseases | 22 | 2023 | 743 | 2.450 |
Why?
|
| Aorta, Thoracic | 28 | 2021 | 1084 | 2.090 |
Why?
|
| Aorta | 16 | 2023 | 2062 | 1.230 |
Why?
|
| Aortic Valve | 19 | 2018 | 1924 | 1.130 |
Why?
|
| Blood Vessel Prosthesis Implantation | 18 | 2022 | 1391 | 1.070 |
Why?
|
| Aortic Valve Insufficiency | 7 | 2019 | 579 | 1.060 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2023 | 144 | 0.970 |
Why?
|
| Registries | 58 | 2022 | 8091 | 0.970 |
Why?
|
| Loeys-Dietz Syndrome | 2 | 2023 | 40 | 0.930 |
Why?
|
| Cardiology | 10 | 2023 | 1668 | 0.920 |
Why?
|
| Vascular Surgical Procedures | 18 | 2016 | 1476 | 0.820 |
Why?
|
| Hospitals, General | 3 | 2022 | 749 | 0.780 |
Why?
|
| Acute Disease | 60 | 2022 | 7147 | 0.770 |
Why?
|
| Aortic Rupture | 8 | 2016 | 312 | 0.730 |
Why?
|
| Heart Valve Diseases | 9 | 2018 | 1074 | 0.670 |
Why?
|
| Losartan | 2 | 2018 | 299 | 0.600 |
Why?
|
| Hospital Mortality | 41 | 2022 | 5316 | 0.590 |
Why?
|
| Hematoma | 7 | 2014 | 758 | 0.530 |
Why?
|
| Echocardiography, Transesophageal | 9 | 2018 | 1133 | 0.530 |
Why?
|
| Aortography | 9 | 2018 | 437 | 0.520 |
Why?
|
| Endovascular Procedures | 9 | 2021 | 1980 | 0.510 |
Why?
|
| American Heart Association | 6 | 2023 | 1057 | 0.480 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2018 | 851 | 0.420 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2014 | 1240 | 0.410 |
Why?
|
| Heart Aneurysm | 2 | 2010 | 120 | 0.390 |
Why?
|
| Echocardiography | 15 | 2022 | 5099 | 0.390 |
Why?
|
| Cardiac Tamponade | 7 | 2014 | 173 | 0.380 |
Why?
|
| Humans | 181 | 2024 | 744366 | 0.340 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2014 | 923 | 0.330 |
Why?
|
| Infarction | 1 | 2010 | 244 | 0.320 |
Why?
|
| Electrocardiography | 11 | 2019 | 6442 | 0.320 |
Why?
|
| Blood Vessel Prosthesis | 6 | 2020 | 934 | 0.320 |
Why?
|
| Chagas Disease | 1 | 2010 | 166 | 0.310 |
Why?
|
| Male | 126 | 2023 | 350115 | 0.310 |
Why?
|
| Aged | 94 | 2022 | 163288 | 0.310 |
Why?
|
| Middle Aged | 102 | 2022 | 213390 | 0.300 |
Why?
|
| Diverticulum | 2 | 2021 | 136 | 0.300 |
Why?
|
| Hypercapnia | 1 | 2008 | 260 | 0.300 |
Why?
|
| Subclavian Artery | 3 | 2023 | 130 | 0.290 |
Why?
|
| Heart Ventricles | 4 | 2019 | 3817 | 0.290 |
Why?
|
| Female | 121 | 2024 | 380193 | 0.290 |
Why?
|
| Monitoring, Physiologic | 3 | 2019 | 1739 | 0.280 |
Why?
|
| Chagas Cardiomyopathy | 2 | 2010 | 71 | 0.260 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2008 | 271 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 18 | 2022 | 20130 | 0.250 |
Why?
|
| Treatment Outcome | 54 | 2022 | 63107 | 0.250 |
Why?
|
| Heart Function Tests | 3 | 2017 | 328 | 0.240 |
Why?
|
| Heart Valve Prosthesis | 5 | 2019 | 1490 | 0.240 |
Why?
|
| Risk Factors | 43 | 2022 | 72296 | 0.230 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2022 | 1504 | 0.230 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2019 | 1537 | 0.230 |
Why?
|
| Europe | 14 | 2018 | 3338 | 0.230 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2016 | 269 | 0.230 |
Why?
|
| Advisory Committees | 3 | 2016 | 775 | 0.220 |
Why?
|
| Aneurysm, Dissecting | 4 | 2002 | 11 | 0.220 |
Why?
|
| Retrospective Studies | 45 | 2022 | 77460 | 0.220 |
Why?
|
| Chronobiology Phenomena | 3 | 2016 | 30 | 0.220 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2021 | 2269 | 0.210 |
Why?
|
| Syncope | 4 | 2004 | 429 | 0.210 |
Why?
|
| Chest Pain | 5 | 2016 | 1114 | 0.210 |
Why?
|
| Image Enhancement | 2 | 2016 | 2921 | 0.200 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2007 | 2073 | 0.200 |
Why?
|
| Myocardial Infarction | 6 | 2024 | 11718 | 0.200 |
Why?
|
| Massachusetts | 6 | 2022 | 8662 | 0.200 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2015 | 1443 | 0.190 |
Why?
|
| Stents | 6 | 2018 | 3282 | 0.190 |
Why?
|
| Sinus of Valsalva | 2 | 2021 | 59 | 0.190 |
Why?
|
| Photoplethysmography | 1 | 2020 | 56 | 0.190 |
Why?
|
| Dilatation, Pathologic | 6 | 2020 | 520 | 0.190 |
Why?
|
| Pleural Effusion | 2 | 2022 | 337 | 0.180 |
Why?
|
| Postoperative Complications | 17 | 2022 | 15297 | 0.180 |
Why?
|
| Heart Failure | 3 | 2018 | 10895 | 0.180 |
Why?
|
| Coronary Angiography | 6 | 2024 | 4576 | 0.180 |
Why?
|
| Pain | 5 | 2015 | 4988 | 0.180 |
Why?
|
| Follow-Up Studies | 24 | 2020 | 39052 | 0.170 |
Why?
|
| Research Report | 1 | 2022 | 355 | 0.170 |
Why?
|
| Models, Cardiovascular | 2 | 2022 | 996 | 0.170 |
Why?
|
| Dyspnea | 2 | 2023 | 1303 | 0.170 |
Why?
|
| Ischemia | 4 | 2014 | 1907 | 0.170 |
Why?
|
| Internationality | 4 | 2013 | 1002 | 0.160 |
Why?
|
| Heart Atria | 2 | 2007 | 1356 | 0.160 |
Why?
|
| Organizational Innovation | 1 | 2022 | 559 | 0.160 |
Why?
|
| Amiodarone | 1 | 2010 | 212 | 0.160 |
Why?
|
| Atenolol | 1 | 2018 | 100 | 0.160 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 236 | 0.160 |
Why?
|
| Predictive Value of Tests | 14 | 2022 | 15078 | 0.160 |
Why?
|
| Puerperal Disorders | 1 | 2021 | 275 | 0.160 |
Why?
|
| Cardiovascular Agents | 6 | 2013 | 850 | 0.160 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2018 | 143 | 0.160 |
Why?
|
| Abortion, Induced | 1 | 2024 | 458 | 0.160 |
Why?
|
| Weill-Marchesani Syndrome | 1 | 2017 | 6 | 0.150 |
Why?
|
| Echocardiography, Doppler | 3 | 2018 | 935 | 0.150 |
Why?
|
| Diagnostic Imaging | 7 | 2014 | 3508 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2021 | 500 | 0.150 |
Why?
|
| Dilatation | 1 | 2018 | 291 | 0.150 |
Why?
|
| Oximetry | 1 | 2020 | 471 | 0.150 |
Why?
|
| Hospitalists | 1 | 2021 | 305 | 0.150 |
Why?
|
| Ventricular Pressure | 1 | 2018 | 199 | 0.150 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2020 | 585 | 0.150 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2018 | 364 | 0.150 |
Why?
|
| Prognosis | 18 | 2016 | 29060 | 0.150 |
Why?
|
| Recurrence | 4 | 2016 | 8340 | 0.140 |
Why?
|
| Shock | 3 | 2016 | 318 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 11 | 2016 | 6539 | 0.140 |
Why?
|
| GATA4 Transcription Factor | 1 | 2017 | 131 | 0.140 |
Why?
|
| United States | 27 | 2023 | 69872 | 0.140 |
Why?
|
| Indazoles | 1 | 2018 | 290 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2024 | 831 | 0.140 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2007 | 1186 | 0.140 |
Why?
|
| Athletes | 2 | 2022 | 1093 | 0.140 |
Why?
|
| Ambulatory Care | 2 | 2018 | 2708 | 0.140 |
Why?
|
| Mitral Valve Prolapse | 2 | 2008 | 231 | 0.140 |
Why?
|
| Coronary Aneurysm | 1 | 2018 | 237 | 0.140 |
Why?
|
| Patient Care | 1 | 2022 | 640 | 0.140 |
Why?
|
| Aortic Valve Stenosis | 2 | 2019 | 1965 | 0.140 |
Why?
|
| Aortic Coarctation | 1 | 2018 | 281 | 0.140 |
Why?
|
| Flank Pain | 2 | 2010 | 43 | 0.130 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2010 | 789 | 0.130 |
Why?
|
| Hypertension | 9 | 2015 | 8479 | 0.130 |
Why?
|
| Foreign Bodies | 1 | 2000 | 400 | 0.130 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2018 | 451 | 0.130 |
Why?
|
| Age Factors | 13 | 2018 | 18373 | 0.130 |
Why?
|
| Vascular Resistance | 1 | 2018 | 936 | 0.130 |
Why?
|
| Quality Improvement | 2 | 2020 | 3749 | 0.130 |
Why?
|
| Societies, Medical | 4 | 2016 | 3743 | 0.130 |
Why?
|
| Survival Rate | 12 | 2018 | 12788 | 0.130 |
Why?
|
| Diagnosis, Differential | 9 | 2013 | 12961 | 0.130 |
Why?
|
| Data Mining | 1 | 2020 | 537 | 0.130 |
Why?
|
| Abdominal Pain | 3 | 2010 | 1064 | 0.120 |
Why?
|
| Risk Assessment | 14 | 2019 | 23336 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 2 | 2022 | 2007 | 0.120 |
Why?
|
| Viscera | 1 | 2014 | 139 | 0.120 |
Why?
|
| Survival Analysis | 12 | 2019 | 10252 | 0.120 |
Why?
|
| Kidney | 1 | 2010 | 7184 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2014 | 3537 | 0.120 |
Why?
|
| Comorbidity | 10 | 2022 | 10388 | 0.120 |
Why?
|
| Patient Preference | 2 | 2018 | 889 | 0.120 |
Why?
|
| Preoperative Care | 2 | 2005 | 2251 | 0.120 |
Why?
|
| Seasons | 4 | 2016 | 1493 | 0.110 |
Why?
|
| Respiratory System | 1 | 2017 | 557 | 0.110 |
Why?
|
| Disease Management | 5 | 2016 | 2460 | 0.110 |
Why?
|
| Adult | 36 | 2021 | 214052 | 0.110 |
Why?
|
| Thoracic Surgery | 2 | 2010 | 719 | 0.110 |
Why?
|
| Ultrasonography | 5 | 2010 | 5984 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 1516 | 0.110 |
Why?
|
| Patient Positioning | 1 | 2016 | 324 | 0.110 |
Why?
|
| Pyridones | 1 | 2018 | 711 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 728 | 0.110 |
Why?
|
| Hypotension | 5 | 2014 | 884 | 0.110 |
Why?
|
| Aorta, Abdominal | 2 | 2013 | 646 | 0.110 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 432 | 0.110 |
Why?
|
| Nomograms | 1 | 2014 | 228 | 0.110 |
Why?
|
| DNA Helicases | 1 | 2018 | 861 | 0.110 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2024 | 1519 | 0.100 |
Why?
|
| Remote Consultation | 1 | 2014 | 238 | 0.100 |
Why?
|
| Time Factors | 16 | 2018 | 40075 | 0.100 |
Why?
|
| Heart Diseases | 5 | 2016 | 2789 | 0.100 |
Why?
|
| Splanchnic Circulation | 1 | 2012 | 110 | 0.100 |
Why?
|
| Systemic Vasculitis | 1 | 2012 | 37 | 0.100 |
Why?
|
| Coronary Vessels | 2 | 2024 | 3107 | 0.100 |
Why?
|
| Pregnancy | 6 | 2024 | 29144 | 0.100 |
Why?
|
| Office Visits | 1 | 2015 | 598 | 0.100 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2022 | 687 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2019 | 1541 | 0.100 |
Why?
|
| Blood Pressure | 3 | 2018 | 8551 | 0.100 |
Why?
|
| Pain Measurement | 1 | 2001 | 3420 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2019 | 944 | 0.100 |
Why?
|
| Reference Values | 4 | 2019 | 4982 | 0.100 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 1152 | 0.090 |
Why?
|
| Patient Transfer | 1 | 2017 | 762 | 0.090 |
Why?
|
| Cocaine-Related Disorders | 1 | 2014 | 460 | 0.090 |
Why?
|
| Antihypertensive Agents | 4 | 2015 | 2047 | 0.090 |
Why?
|
| Nifurtimox | 1 | 2010 | 13 | 0.090 |
Why?
|
| Aged, 80 and over | 20 | 2020 | 57776 | 0.090 |
Why?
|
| Acute Coronary Syndrome | 1 | 2024 | 2337 | 0.090 |
Why?
|
| Odds Ratio | 9 | 2014 | 9849 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 373 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 4 | 2015 | 7282 | 0.090 |
Why?
|
| Pericardium | 1 | 1994 | 667 | 0.090 |
Why?
|
| Trypanocidal Agents | 1 | 2010 | 38 | 0.090 |
Why?
|
| Patient Participation | 1 | 2019 | 1457 | 0.090 |
Why?
|
| Heart | 3 | 2024 | 4464 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 1831 | 0.090 |
Why?
|
| Chi-Square Distribution | 5 | 2014 | 3508 | 0.090 |
Why?
|
| Reoperation | 6 | 2018 | 4201 | 0.090 |
Why?
|
| Cost Savings | 1 | 2014 | 925 | 0.090 |
Why?
|
| Severity of Illness Index | 9 | 2018 | 15535 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 2865 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1405 | 0.080 |
Why?
|
| Oxygen | 1 | 2020 | 4189 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 1956 | 0.080 |
Why?
|
| Aortitis | 1 | 2009 | 74 | 0.080 |
Why?
|
| Thrombosis | 3 | 2014 | 2968 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1257 | 0.080 |
Why?
|
| Case Management | 3 | 2006 | 286 | 0.080 |
Why?
|
| Cocaine | 1 | 2014 | 1007 | 0.080 |
Why?
|
| Algorithms | 5 | 2021 | 13882 | 0.080 |
Why?
|
| Sex Distribution | 4 | 2009 | 2297 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 1178 | 0.080 |
Why?
|
| Incidence | 11 | 2016 | 20952 | 0.080 |
Why?
|
| Medical Records | 3 | 2006 | 1413 | 0.080 |
Why?
|
| Delayed Diagnosis | 1 | 2011 | 441 | 0.080 |
Why?
|
| Giant Cell Arteritis | 1 | 2012 | 292 | 0.080 |
Why?
|
| Artifacts | 1 | 2016 | 1904 | 0.070 |
Why?
|
| Heart Defects, Congenital | 2 | 2021 | 4583 | 0.070 |
Why?
|
| Stroke | 5 | 2021 | 9981 | 0.070 |
Why?
|
| Immune System Diseases | 1 | 2009 | 261 | 0.070 |
Why?
|
| Cardiovascular Diseases | 3 | 2020 | 15160 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2018 | 3024 | 0.070 |
Why?
|
| Health Behavior | 1 | 2018 | 2635 | 0.070 |
Why?
|
| Thrombolytic Therapy | 1 | 1996 | 2162 | 0.070 |
Why?
|
| Logistic Models | 8 | 2018 | 13409 | 0.070 |
Why?
|
| Stroke Volume | 2 | 2018 | 5006 | 0.070 |
Why?
|
| Radiography, Abdominal | 1 | 2010 | 537 | 0.070 |
Why?
|
| Emergency Service, Hospital | 2 | 2016 | 7658 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2016 | 2265 | 0.070 |
Why?
|
| Exercise Test | 3 | 2020 | 2073 | 0.070 |
Why?
|
| Pyrophosphatases | 1 | 1986 | 137 | 0.070 |
Why?
|
| Intracranial Embolism | 1 | 2007 | 202 | 0.060 |
Why?
|
| Bartonella Infections | 1 | 2005 | 22 | 0.060 |
Why?
|
| DNA Glycosylases | 1 | 1986 | 128 | 0.060 |
Why?
|
| Uracil | 1 | 1986 | 165 | 0.060 |
Why?
|
| Positive-Pressure Respiration | 1 | 2008 | 633 | 0.060 |
Why?
|
| International Cooperation | 3 | 2008 | 1420 | 0.060 |
Why?
|
| Swine | 3 | 2019 | 5918 | 0.060 |
Why?
|
| Inpatients | 2 | 2021 | 2518 | 0.060 |
Why?
|
| Movement Disorders | 1 | 2007 | 446 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 6486 | 0.060 |
Why?
|
| Prospective Studies | 11 | 2020 | 53290 | 0.060 |
Why?
|
| Exercise | 1 | 2020 | 5615 | 0.060 |
Why?
|
| Heart Neoplasms | 1 | 2007 | 374 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2012 | 1161 | 0.060 |
Why?
|
| Patient Selection | 6 | 2015 | 4216 | 0.060 |
Why?
|
| Phenotype | 5 | 2018 | 16367 | 0.060 |
Why?
|
| Sex Factors | 4 | 2018 | 10400 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5856 | 0.050 |
Why?
|
| Survivors | 1 | 2013 | 2291 | 0.050 |
Why?
|
| RNA, Nuclear | 1 | 2022 | 30 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3531 | 0.050 |
Why?
|
| Emergency Medical Services | 2 | 2011 | 1917 | 0.050 |
Why?
|
| Crack Cocaine | 1 | 2002 | 32 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2020 | 1534 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 17446 | 0.050 |
Why?
|
| Cohort Studies | 10 | 2022 | 40559 | 0.050 |
Why?
|
| Body Weights and Measures | 1 | 2022 | 211 | 0.050 |
Why?
|
| Renal Insufficiency | 2 | 2006 | 804 | 0.050 |
Why?
|
| Decision Trees | 1 | 2004 | 506 | 0.050 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 2 | 2015 | 153 | 0.050 |
Why?
|
| Probability | 2 | 2005 | 2506 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2004 | 550 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2017 | 6542 | 0.050 |
Why?
|
| Angina Pectoris | 2 | 2016 | 977 | 0.050 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 12262 | 0.050 |
Why?
|
| Actinin | 1 | 2022 | 160 | 0.050 |
Why?
|
| Age Distribution | 2 | 2005 | 2902 | 0.050 |
Why?
|
| Embolism, Air | 1 | 2002 | 111 | 0.050 |
Why?
|
| Pericardial Effusion | 2 | 2012 | 247 | 0.050 |
Why?
|
| Proteus vulgaris | 1 | 2000 | 7 | 0.050 |
Why?
|
| Proteus Infections | 1 | 2000 | 10 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2019 | 2110 | 0.050 |
Why?
|
| Telemedicine | 1 | 2018 | 2872 | 0.050 |
Why?
|
| Hysteroscopy | 1 | 2002 | 102 | 0.050 |
Why?
|
| Canada | 2 | 2018 | 2065 | 0.050 |
Why?
|
| Aortic Valve Prolapse | 1 | 2000 | 10 | 0.050 |
Why?
|
| Mutation | 4 | 2018 | 29786 | 0.050 |
Why?
|
| Pilot Projects | 4 | 2019 | 8319 | 0.050 |
Why?
|
| Mediastinitis | 1 | 2000 | 48 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2005 | 455 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2022 | 35425 | 0.050 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2018 | 964 | 0.050 |
Why?
|
| Technology Transfer | 1 | 2020 | 44 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2007 | 934 | 0.050 |
Why?
|
| Case-Control Studies | 5 | 2017 | 21748 | 0.040 |
Why?
|
| Japan | 3 | 2012 | 1360 | 0.040 |
Why?
|
| Multivariate Analysis | 5 | 2014 | 12244 | 0.040 |
Why?
|
| Wireless Technology | 1 | 2020 | 100 | 0.040 |
Why?
|
| Spinal Cord Ischemia | 2 | 2014 | 94 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 18034 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 1092 | 0.040 |
Why?
|
| Radiography | 3 | 2016 | 7023 | 0.040 |
Why?
|
| Hospitalization | 5 | 2016 | 10259 | 0.040 |
Why?
|
| Young Adult | 7 | 2023 | 56429 | 0.040 |
Why?
|
| North America | 2 | 2013 | 1249 | 0.040 |
Why?
|
| Methotrexate | 1 | 1986 | 1728 | 0.040 |
Why?
|
| Morbidity | 2 | 2015 | 1768 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2018 | 14561 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 3505 | 0.040 |
Why?
|
| Patient Discharge | 3 | 2022 | 3318 | 0.040 |
Why?
|
| Coronary Artery Bypass | 2 | 2005 | 2288 | 0.040 |
Why?
|
| Respiratory Rate | 1 | 2019 | 162 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12207 | 0.040 |
Why?
|
| Computers | 1 | 2020 | 612 | 0.040 |
Why?
|
| Early Diagnosis | 2 | 2014 | 1184 | 0.040 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2020 | 271 | 0.040 |
Why?
|
| Histones | 2 | 2018 | 2598 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 4561 | 0.040 |
Why?
|
| Actomyosin | 1 | 2018 | 111 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 951 | 0.040 |
Why?
|
| Tidal Volume | 1 | 2019 | 490 | 0.040 |
Why?
|
| Boston | 2 | 2018 | 9312 | 0.040 |
Why?
|
| Ontario | 1 | 2017 | 383 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2001 | 793 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 172 | 0.030 |
Why?
|
| Proportional Hazards Models | 4 | 2014 | 12356 | 0.030 |
Why?
|
| Circadian Rhythm | 2 | 2005 | 2624 | 0.030 |
Why?
|
| Aftercare | 1 | 2022 | 870 | 0.030 |
Why?
|
| Organ Size | 1 | 2021 | 2251 | 0.030 |
Why?
|
| Cell Survival | 1 | 1986 | 5882 | 0.030 |
Why?
|
| Sarcoma | 1 | 2007 | 1897 | 0.030 |
Why?
|
| Hemodynamics | 3 | 2015 | 4196 | 0.030 |
Why?
|
| Hand | 1 | 2020 | 884 | 0.030 |
Why?
|
| Life Tables | 2 | 2006 | 370 | 0.030 |
Why?
|
| Acute Kidney Injury | 3 | 2014 | 1968 | 0.030 |
Why?
|
| Emergencies | 1 | 2021 | 1170 | 0.030 |
Why?
|
| Asia | 2 | 2010 | 609 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 808 | 0.030 |
Why?
|
| Sensitivity and Specificity | 5 | 2016 | 14723 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2020 | 719 | 0.030 |
Why?
|
| Prosthesis-Related Infections | 1 | 2000 | 538 | 0.030 |
Why?
|
| Vascular Patency | 2 | 2007 | 887 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 2012 | 0.030 |
Why?
|
| Shock, Cardiogenic | 1 | 1999 | 688 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 1423 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2018 | 4285 | 0.030 |
Why?
|
| Risk | 3 | 2015 | 9688 | 0.030 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3611 | 0.030 |
Why?
|
| Body Size | 1 | 2016 | 461 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 2505 | 0.030 |
Why?
|
| Death, Sudden | 1 | 2015 | 302 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 453 | 0.030 |
Why?
|
| Animals | 7 | 2019 | 168768 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2023 | 2585 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2018 | 1235 | 0.030 |
Why?
|
| Linear Models | 2 | 2014 | 5953 | 0.030 |
Why?
|
| New England | 1 | 2015 | 1022 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 1617 | 0.030 |
Why?
|
| Body Surface Area | 1 | 2013 | 199 | 0.030 |
Why?
|
| Pulse | 1 | 2012 | 229 | 0.030 |
Why?
|
| Italy | 1 | 2014 | 832 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2018 | 1158 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 1793 | 0.030 |
Why?
|
| Bioprosthesis | 1 | 2017 | 597 | 0.030 |
Why?
|
| Radionuclide Imaging | 2 | 2007 | 2031 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 1999 | 2307 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2024 | 2657 | 0.020 |
Why?
|
| Glucocorticoids | 2 | 2012 | 2108 | 0.020 |
Why?
|
| Cognition | 1 | 2008 | 6770 | 0.020 |
Why?
|
| Leadership | 1 | 2020 | 1357 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 1525 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 19905 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2019 | 1273 | 0.020 |
Why?
|
| Heterozygote | 1 | 2017 | 2804 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 789 | 0.020 |
Why?
|
| Critical Pathways | 1 | 2014 | 476 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2005 | 1066 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 6489 | 0.020 |
Why?
|
| Atherosclerosis | 3 | 2015 | 3444 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4642 | 0.020 |
Why?
|
| Confidence Intervals | 2 | 2005 | 2971 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2017 | 41005 | 0.020 |
Why?
|
| RNA Interference | 1 | 2018 | 2890 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2018 | 2969 | 0.020 |
Why?
|
| Mice | 4 | 2018 | 81201 | 0.020 |
Why?
|
| Outpatients | 1 | 2016 | 1487 | 0.020 |
Why?
|
| Disease Progression | 2 | 2018 | 13286 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1707 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3680 | 0.020 |
Why?
|
| Observer Variation | 1 | 2014 | 2593 | 0.020 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1998 | 1421 | 0.020 |
Why?
|
| Length of Stay | 1 | 2001 | 6311 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 2566 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2018 | 19233 | 0.020 |
Why?
|
| Syndrome | 1 | 2014 | 3252 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3528 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2453 | 0.020 |
Why?
|
| Zebrafish | 1 | 2018 | 2996 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2005 | 4639 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 13991 | 0.020 |
Why?
|
| Propensity Score | 1 | 2013 | 1781 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 2960 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2926 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 1997 | 0.020 |
Why?
|
| Thymine Nucleotides | 1 | 1986 | 63 | 0.020 |
Why?
|
| Chromatin | 1 | 2018 | 2933 | 0.020 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 1986 | 31 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2760 | 0.020 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1986 | 68 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3486 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1736 | 0.020 |
Why?
|
| Heart-Lung Machine | 1 | 2005 | 43 | 0.020 |
Why?
|
| Paraplegia | 1 | 2006 | 169 | 0.020 |
Why?
|
| Bartonella | 1 | 2005 | 12 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 3666 | 0.020 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 1 | 2005 | 63 | 0.020 |
Why?
|
| Dipyridamole | 1 | 2005 | 145 | 0.020 |
Why?
|
| DNA | 2 | 2011 | 7294 | 0.020 |
Why?
|
| Prednisone | 1 | 2009 | 1574 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3646 | 0.020 |
Why?
|
| Nitroprusside | 1 | 2004 | 275 | 0.020 |
Why?
|
| Climate | 1 | 2005 | 147 | 0.010 |
Why?
|
| Limb Salvage | 1 | 2006 | 433 | 0.010 |
Why?
|
| Heart Arrest, Induced | 1 | 2005 | 355 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 16000 | 0.010 |
Why?
|
| Heart Block | 1 | 2005 | 410 | 0.010 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2004 | 138 | 0.010 |
Why?
|
| Endosonography | 1 | 2007 | 610 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2008 | 970 | 0.010 |
Why?
|
| Adolescent | 3 | 2018 | 85779 | 0.010 |
Why?
|
| Renal Artery Obstruction | 1 | 2004 | 248 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2006 | 987 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 25039 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 1265 | 0.010 |
Why?
|
| beta-Thromboglobulin | 1 | 2002 | 24 | 0.010 |
Why?
|
| Biological Clocks | 1 | 2005 | 322 | 0.010 |
Why?
|
| Systole | 1 | 2004 | 958 | 0.010 |
Why?
|
| Diastole | 1 | 2004 | 791 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 2005 | 414 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2011 | 2575 | 0.010 |
Why?
|
| Mitral Valve | 2 | 2002 | 1491 | 0.010 |
Why?
|
| Intermittent Claudication | 1 | 2004 | 309 | 0.010 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5749 | 0.010 |
Why?
|
| Radiology | 1 | 2016 | 2099 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 1641 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2002 | 447 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 692 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2014 | 3208 | 0.010 |
Why?
|
| Abscess | 1 | 2005 | 607 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2002 | 588 | 0.010 |
Why?
|
| Extremities | 1 | 2006 | 866 | 0.010 |
Why?
|
| Cause of Death | 1 | 2011 | 3582 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 2001 | 183 | 0.010 |
Why?
|
| Periodicity | 1 | 2002 | 364 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2005 | 767 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3841 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3047 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 2005 | 841 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 21833 | 0.010 |
Why?
|
| Povidone-Iodine | 1 | 2000 | 59 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2007 | 1406 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2015 | 7730 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 4805 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1851 | 0.010 |
Why?
|
| Cattle | 1 | 1986 | 3922 | 0.010 |
Why?
|
| Consciousness Disorders | 1 | 2004 | 418 | 0.010 |
Why?
|
| Iliac Artery | 1 | 2001 | 364 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 3922 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 1782 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 2000 | 301 | 0.010 |
Why?
|
| Microspheres | 1 | 2002 | 777 | 0.010 |
Why?
|
| Renal Artery | 1 | 2001 | 399 | 0.010 |
Why?
|
| Creatinine | 1 | 2004 | 1919 | 0.010 |
Why?
|
| Diagnostic Techniques, Surgical | 1 | 1998 | 10 | 0.010 |
Why?
|
| Critical Illness | 1 | 2011 | 2670 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 2002 | 547 | 0.010 |
Why?
|
| Smoking | 1 | 2015 | 8987 | 0.010 |
Why?
|
| Carotid Artery Diseases | 1 | 2004 | 879 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2007 | 1332 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1986 | 2967 | 0.010 |
Why?
|
| Embolization, Therapeutic | 1 | 2006 | 1392 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 5321 | 0.010 |
Why?
|
| Videotape Recording | 1 | 1998 | 352 | 0.010 |
Why?
|
| Leg | 1 | 2001 | 1116 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 4092 | 0.010 |
Why?
|
| Angiography | 1 | 2001 | 1639 | 0.010 |
Why?
|
| Child | 2 | 2017 | 77709 | 0.010 |
Why?
|
| Research | 1 | 2004 | 1999 | 0.010 |
Why?
|
| Forecasting | 1 | 2004 | 2951 | 0.010 |
Why?
|
| Mortality | 1 | 2006 | 2864 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23404 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2007 | 3589 | 0.010 |
Why?
|
| Alcoholism | 1 | 2005 | 1906 | 0.010 |
Why?
|
| Reference Standards | 1 | 1998 | 1025 | 0.010 |
Why?
|
| Contrast Media | 1 | 2007 | 5300 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1998 | 1206 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8642 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 15520 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2000 | 1640 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2004 | 2535 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 1998 | 957 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 2000 | 1540 | 0.010 |
Why?
|
| Hospitals | 1 | 2005 | 3954 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1993 | 306 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1993 | 980 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 1998 | 1486 | 0.010 |
Why?
|
| Infant | 1 | 2008 | 35134 | 0.000 |
Why?
|
| Lung | 1 | 2005 | 9857 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 8861 | 0.000 |
Why?
|
| Models, Statistical | 1 | 2000 | 5101 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1998 | 8949 | 0.000 |
Why?
|